Certainly.
Of course, we are not involved in the commercialization of those companies. We're involved in the research up front that is used to launch those.
There's one example of a company in Ontario, DVS Sciences Inc., which has actually developed a mass spectrometry technology. They produce equipment that is used by researchers around the world and should be used for clinical purposes. That's one example.
Another example is one on colorectal cancer. They have developed a diagnostic test that should be able to identify a certain percentage of those at risk for colon cancer earlier than they did in the past so that they can be directed to the appropriate treatment. That's a diagnostic test that has spun out into a company.
Let me think of some more examples of companies. We have a company that is involved in transplantation transcriptomics that looks at biomarkers that are produced when there are problems with the transplantation of organs.